Soligenix, Inc. Sample Contracts

AutoNDA by SimpleDocs
WARRANT TO PURCHASE SHARES OF COMMON STOCK
Soligenix, Inc. • January 16th, 2024 • Pharmaceutical preparations

THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [•], 20291 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Soligenix, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

UNDERWRITING AGREEMENT between SOLIGENIX, INC. And
Underwriting Agreement • June 18th, 2018 • Soligenix, Inc. • Pharmaceutical preparations • New York

The undersigned, Soligenix, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Soligenix, Inc. (the “Company”)), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:

BY AND BETWEEN ENDOREX CORPORATION AND COLIN BIER
Employment Agreement • October 2nd, 2001 • Endorex Corp • Pharmaceutical preparations • Illinois
LICENSE AGREEMENT
Agreement • November 13th, 1998 • Endorex Corp • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENT
Employment Agreement • March 30th, 2000 • Endorex Corp • Pharmaceutical preparations • Illinois
AND
Termination Agreement • March 31st, 2003 • Dor Biopharma Inc • Pharmaceutical preparations • New York
JOINT FILING AGREEMENT
Joint Filing Agreement • November 13th, 2003 • Dor Biopharma Inc • Pharmaceutical preparations

The undersigned hereby agree that the Statement on this Schedule 13G, dated November 14, 2003, (the "Schedule 13G"), with respect to the Common Stock, par value $.001 per share, of Dor Biopharma,Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

WITNESSETH:
Purchase Agreement • December 29th, 2000 • Endorex Corp • Pharmaceutical preparations • New Jersey
WITNESSETH:
Purchase Agreement • May 12th, 1997 • Endorex Corp • Pharmaceutical preparations • New York
FIRST AMENDMENT
License Agreement • October 2nd, 2001 • Endorex Corp • Pharmaceutical preparations
COMMON STOCK PURCHASE WARRANT
Common Stock Purchase Warrant • May 8th, 2013 • Soligenix, Inc. • Pharmaceutical preparations

This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the [ ] year anniversary of the Initial Exercise Date (as such date may be changed pursuant to Section 3 hereof, the “Termination Date”) but not thereafter, to subscribe for and purchase from Soligenix, Inc., a Delaware corporation (the “Company”), up to ___________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 16th, 2024 • Soligenix, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of [·], 2024, between Soligenix, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 24th, 2016 • Soligenix, Inc. • Pharmaceutical preparations • Illinois

REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of March 22, 2016, by and between SOLIGENIX, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").

AutoNDA by SimpleDocs
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 31st, 2017 • Soligenix, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October 31, 2017, between Soligenix, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

ENDOREX CORP.
Endorex Corp • March 27th, 1998 • Pharmaceutical preparations • New York
DOR BIOPHARMA, INC. and American Stock Transfer & Trust Company, as Rights Agent RIGHTS AGREEMENT Dated as of June 22, 2007
Rights Agreement • June 22nd, 2007 • Dor Biopharma Inc • Pharmaceutical preparations • Delaware

Rights Agreement, dated as of June 22, 2007 (“Agreement”), between Dor BioPharma, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, as Rights Agent (the “Rights Agent”).

ARTICLE I VOTING AGREEMENT
Voting Agreement • August 14th, 2001 • Endorex Corp • Pharmaceutical preparations • Delaware
LEASE AGREEMENT
Lease Agreement • March 27th, 1998 • Endorex Corp • Pharmaceutical preparations • Illinois
PURCHASE AGREEMENT
Purchase Agreement • March 24th, 2016 • Soligenix, Inc. • Pharmaceutical preparations • Illinois

PURCHASE AGREEMENT (the “Agreement”), dated as of March 22, 2016, by and between SOLIGENIX, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).

EQUITY PURCHASE AGREEMENT
Equity Purchase Agreement • July 31st, 2015 • Soligenix, Inc. • Pharmaceutical preparations • New York

THIS EQUITY PURCHASE AGREEMENT entered into as of the [______] day of July, 2015 (this "AGREEMENT"), by and between [______], a [STATE] [TYPE OF ENTITY] ("INVESTOR"), and SOLIGENIX, INC., a Delaware Corporation (the "COMPANY").

Form of Placement Agent’s Warrant Agreement
Soligenix, Inc. • October 31st, 2017 • Pharmaceutical preparations • New York

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS 180 DAYS FROM THE CLOSING DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE CLOSING DATE OF THE OFFERING].

Time is Money Join Law Insider Premium to draft better contracts faster.